Get startedLog in
    Picture of Shedir Pharma Srl Unipersonale logo

    SHE — Shedir Pharma Srl Unipersonale Income Statement

    0.000.00%
    it flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Shedir Pharma Srl Unipersonale, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue50.24344.753.559.4
    Cost of Revenue
    Gross Profit30.925.425.830.335.8
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses44.937.138.845.251
    Operating Profit5.275.975.918.38.39
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes4.915.315.78.248.08
    Provision for Income Taxes
    Net Income After Taxes2.873.963.955.955.72
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income2.843.933.925.925.7
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income2.843.933.925.925.7
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.4010.3940.3190.4470.508
    Dividends per Share